Format

Send to

Choose Destination
Pediatr Nephrol. 2005 Apr;20(4):447-51. Epub 2005 Feb 17.

Glucose transporters in diabetic nephropathy.

Author information

1
Departments of Internal Medicine and Physiology, University of Michigan, Ann Arbor, MI 48109-0676, USA. fbrosius@umich.edu

Abstract

Changes in glucose transporter expression in glomerular cells occur early in diabetes. These changes, especially the GLUT1 increase in mesangial cells, appear to play a pathogenic role in the development of ECM expansion and perhaps other features of diabetic nephropathy. In addition, it appears that at least some diabetic patients may be predisposed to nephropathy because of polymorphisms in their GLUT1 genes. GLUT1 overexpression leads to increased glucose metabolic flux which in turn triggers the polyol pathway and activation of PKC alpha and B1. Activation of these PKC isoforms can lead directly to AP-1 induced increases in fibronectin expression and ECM accumulation. Other, more novel effects of GLUT1 on cellular hypertrophy and injury could also promote changes of diabetic nephropathy. Strategies to prevent GLUT1 overexpression could ameliorate or prevent the progression of diabetic nephropathy.

PMID:
15717166
DOI:
10.1007/s00467-004-1748-x
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Springer Icon for MLibrary (Deep Blue)
Loading ...
Support Center